Christoffer Rosenblad
Net worth: 2 M $ as of 30/05/2026
Net worth: 2 M $ as of 30/05/2026
Christoffer Rosenblad is currently Chief Executive Officer at Xvivo Perfusion AB since 2022, Director at Bentley Endovascular Group AB, and Independent Director at Sedana Medical AB since 2020.
Formerly, Mr. Rosenblad worked as Controller at Ciba Vision Nordic AB. Education includes a graduate degree from Chalmers University of Technology and an MBA from Handelshögskolan i Göteborg.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
XVIVO PERFUSION AB 0.17% | 28/07/2025 | 53,523 ( 0.17% ) | 2 M $ | 30/05/2026 |
SEDANA MEDICAL AB 0.02% | 30/12/2024 | 20,000 ( 0.02% ) | 20 383 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| XVIVO PERFUSION AB | Chief Executive Officer | 26/09/2022 |
| SEDANA MEDICAL AB | Director/Board Member | 18/05/2020 |
| Companies | Position | End |
|---|---|---|
Ciba Vision Nordic AB | Comptroller/Controller/Auditor | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Handelshögskolan i Göteborg
Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ciba Vision Nordic AB | |
Xvivo Perfusion AB
Xvivo Perfusion AB Medical SpecialtiesHealth Technology Operates as a medical technology company which develops solutions for organ, tissue, and cell preservation | Health Technology |
Sedana Medical AB
Sedana Medical AB Medical SpecialtiesHealth Technology Develops and wholesales medical devices and drugs | Health Technology |
Select your edition
All financial news and data tailored to specific country editions